ArticleBritish journal of cancer2013

Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer.

M Nishio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.